Disease Education Resources
Please select your disease state of interest to explore medical education resources.
Learn about clinical & pathological features that may increase the risk of recurrence in patients with HR+,HER2- early breast cancer.
A short educational series of videos & slides about Ki-67 as a prognostic factor for recurrence in patients with HR+/HER2- EBC
~20% of patients with HR+/HER2- EBC may progress to metastatic disease, commonly within a few years after primary treatment. This slide deck provides details on the clinical & pathological factors that may affect the risk of recurrence in people with EBC.
This slide deck is intended to educate Health Care Providers on factors that influence medication adherence/persistence, and provides tools, resources, and guidelines to help improve adherence for their patients.